Cotransplantation of haploidentical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemia.
Fang
Baijun
B
Henan Tumor Hospital, Henan Institute of Hematology, University of Henan Medical School, Zhengzhou, China.
Song
Yongping
Y
Li
Ning
N
Li
Jing
J
Zhao
Robert Chunhua
RC
D000328:Adult; D000707:Anaphylaxis / Q000209:etiology / Q000517:prevention & control; D000753:Anemia, Refractory / Q000601:surgery* / Q000628:therapy; D002478:Cells, Cultured / Q000187:drug effects / Q000637:transplantation; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D019650:Hematopoietic Stem Cell Mobilization; D006648:Histocompatibility; D006801:Humans; D007165:Immunosuppression Therapy; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects; D036102:Peripheral Blood Stem Cell Transplantation; D012008:Recurrence; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous / Q000276:immunology
D036341:Intercellular Signaling Peptides and Proteins